KindlyMD to Participate in H.C. Wainwright’s 26th Annual Global Investment Conference on September 9-11, 2024
Rhea-AI Summary
KindlyMD (NASDAQ: KDLY), a healthcare company integrating traditional primary care with pain management and alternative therapies, announces CEO Tim Pickett's participation in H.C. Wainwright's 26th Annual Global Investment Conference. The event will take place from September 9-11, 2024, at the Lotte New York Palace Hotel.
Key points:
- Pickett will present virtually and engage in one-on-one investor meetings
- The presentation will be available on-demand from 7:00 a.m. ET
- Investors can schedule meetings through H.C. Wainwright representatives or KCSA Strategic Communications
- A replay of the presentation will be accessible for at least 90 days on KindlyMD's investor website
This conference provides KindlyMD an opportunity to showcase its unique approach to healthcare and connect with potential investors.
Positive
- None.
Negative
- None.
News Market Reaction – KDLY
On the day this news was published, KDLY declined 1.64%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
SALT LAKE CITY, UT / ACCESSWIRE / August 26, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, is pleased to announce that KindlyMD CEO, Tim Pickett, will participate in H.C. Wainwright's 26th Annual Global Investment Conference being held at the Lotte New York Palace Hotel in New York City on September 9-11, 2024.
Mr. Pickett will present virtually, as well as take part in one-on-one investor meetings during the conference.
H.C. Wainwright 26th Annual Global Investment Conference
Date: September 9-11, 2024
Time: Presentation available on demand from 7:00 a.m. ET
Location: Lotte New York Palace Hotel, New York
Speaker: Tim Pickett, CEO
Webcast: https://journey.ct.events/view/c4d3d1ce-2ac4-43a6-ac75-8ff358a8f3d9
To schedule a one-on-one investor meeting with Mr. Pickett, please contact your H.C. Wainwright representative or KCSA Strategic Communications at KindlyMD@KCSA.com.
A replay of this presentation will be available for at least 90 days following the date of the presentation on the Company's website at https://investors.kindlymd.com/events-presentations.
About KindlyMD
KindlyMD™️ is a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies to offer patients comprehensive care and reduce the addiction and dependency of opioid use in the U.S. KindlyMD currently operates four centers including the largest alternative pain treatment center in Utah. With a focus on holistic pain management through its specialty outpatient clinical services, including, where appropriate, the recommendation of medical cannabis by KindlyMD healthcare providers, KindlyMD is providing better patient health outcomes.
For more information, please visit www.kindlymd.com.
Investor Relations Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
(212) 896-1254
KindlyMD@KCSA.com
SOURCE: KindlyMD, Inc
View the original press release on accesswire.com